01—Abstract
Summary
Summary of the 8-K filed October 10, 2024. Cited figures are marked; the original filing is the authoritative source.
Cardinal Health Inc. (CAH) has entered into a new 364-Day Credit Agreement, securing access to a $1.0 billiona revolving credit facility maturing on October 7, 2025.
This facility is intended for general corporate purposes and will back the company's commercial paper program. The agreement includes standard covenants, with a key financial covenant requiring a Consolidated Net Leverage Ratio of no greater than 3.75 to 1.00.
Additionally, the company has amended its Issuing and Paying Agency Agreement to increase the maximum principal amount of commercial paper notes outstanding from $2.0 billion to $3.0 billionb. These actions indicate a proactive approach to managing liquidity and financing needs.
02—Key points
Key Highlights
- Secured a new $1.0 billion 364-Day Credit Agreement providing revolving credit access until October 7, 2025.
- The new credit facility is designated for general corporate purposes and supports the company's commercial paper program.
- A key financial covenant mandates a Consolidated Net Leverage Ratio of no more than 3.75 to 1.00.
- Increased the maximum authorized amount for outstanding commercial paper notes from $2.0 billion to $3.0 billion.
- The company retains the option to convert outstanding loans into non-revolving term loans, repayable one year after the termination date.
- Interest rates on borrowings are variable, based on Term SOFR and the company's credit ratings.
03—Questions
Frequently Asked Questions
What is the purpose of the new credit agreement?
The new $1.0 billion 364-Day Credit Agreement is primarily for general corporate purposes and to provide backing for Cardinal Health's commercial paper program, ensuring liquidity and financial flexibility.
What are the key financial covenants in the new credit agreement?
The most significant financial covenant requires Cardinal Health to maintain a Consolidated Net Leverage Ratio of no greater than 3.75 to 1.00 as of the last day of any fiscal quarter.
How does the increase in the commercial paper program affect the company's financing?
Increasing the maximum principal amount of commercial paper notes from $2.0 billion to $3.0 billion allows Cardinal Health greater flexibility to utilize this short-term borrowing instrument for its funding needs.
What happens to loans under the credit agreement on the termination date?
On the Termination Date (October 7, 2025), the company has the option, subject to certain conditions, to convert outstanding loans into non-revolving term loans that would mature one year later.
04—Continue